KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $22.6 million.

  • Neogenomics' Accounts Payables rose 3692.02% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 million, marking a year-over-year increase of 3692.02%. This contributed to the annual value of $21.6 million for FY2024, which is 626.05% up from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Accounts Payables is $22.6 million, which was up 3692.02% from $27.5 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Accounts Payables registered a high of $28.5 million during Q3 2021, and its lowest value of $13.7 million during Q3 2022.
  • Over the past 5 years, Neogenomics' median Accounts Payables value was $18.9 million (recorded in 2021), while the average stood at $19.9 million.
  • In the last 5 years, Neogenomics' Accounts Payables soared by 6090.22% in 2021 and then crashed by 5196.24% in 2022.
  • Over the past 5 years, Neogenomics' Accounts Payables (Quarter) stood at $17.9 million in 2021, then rose by 14.45% to $20.5 million in 2022, then dropped by 0.86% to $20.3 million in 2023, then rose by 6.26% to $21.6 million in 2024, then increased by 4.65% to $22.6 million in 2025.
  • Its Accounts Payables was $22.6 million in Q3 2025, compared to $27.5 million in Q2 2025 and $16.2 million in Q1 2025.